J-Pharma Co.,Ltd.

J-Pharma Co., Ltd. is a drug discovery and development company focused on amino acid transporters as drug targets. It researches and develops drugs targeting solute carrier (SLC) transporters, with particular emphasis on the LAT1 amino acid transporter. Its pipeline includes compounds for various medical indications, such as JPH034 for central nervous system demyelinating diseases and multiple sclerosis. The company conducts functional and structural analysis of selected SLC transporters, collaborates with academic institutions, and participates in joint research for new pharmaceutical development, while preparing for clinical trials and global distribution of its drug candidates. Founded in 2005, it is based in Yokohama, Japan.